Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Change in Accured Expenses (2023 - 2026)

Compass Therapeutics' Change in Accured Expenses history spans 4 years, with the latest figure at -$3.4 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 148.84% to -$3.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$5.2 million, a 145.74% decrease, with the full-year FY2025 number at $5.1 million, up 35.06% from a year prior.
  • Change in Accured Expenses hit -$3.4 million in Q1 2026 for Compass Therapeutics, down from $2.7 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for CMPX hit a ceiling of $6.9 million in Q1 2025 and a floor of -$4.3 million in Q3 2024.
  • Historically, Change in Accured Expenses has averaged -$283846.2 across 4 years, with a median of -$2.2 million in 2023.
  • Biggest five-year swings in Change in Accured Expenses: soared 1090.99% in 2025 and later crashed 148.84% in 2026.
  • Tracing CMPX's Change in Accured Expenses over 4 years: stood at -$3.1 million in 2023, then surged by 207.7% to $3.4 million in 2024, then decreased by 19.93% to $2.7 million in 2025, then crashed by 225.34% to -$3.4 million in 2026.
  • Business Quant data shows Change in Accured Expenses for CMPX at -$3.4 million in Q1 2026, $2.7 million in Q4 2025, and -$2.3 million in Q3 2025.